Document:

EX-4.1

 Exhibit 4.1 
  

	
	

 THIS CERTIFIES THAT: 
Shareholder Name 
IS REGISTERED AS THE HOLDER OF: 
**X** 
SHARES: 
Ordinary shares 
SPECIMEN 
of X shares, with a nominal value of twenty-five euro cent (EUR 0.25) each, of
Arrival, a société anonyme governed by the laws of the Grand Duchy of Luxembourg, with registered office at 1, rue Peternelchen, L-2370 Howald, Grand Duchy of Luxembourg, incorporated following a
deed of the undersigned notary, of 27 October 2020, published in the Luxembourg electronic platform of companies and associations (Recueil Electronique des Sociétés et Associations) number RESA_2020_246.1214 of 3 November
2020 and registered with the Luxembourg Register of Commerce and Companies under number B 248209 (the “Company”). This certificate assures his owner, as registered in the shareholders’ register of the Company, of any rights which,
pursuant to the articles of incorporation, are attached to the ownership of the shares of the Company. It may be exchanged at any moment at the registered office of the Company or at the places designated by it against other certificates
representing in total the same number of shares. 
See reverse for certain definitions. 
CERTIFICATE NUMBER: 
XXXXXXXXXX 
DATED: 
DD.MM.YYYY 
CUSIP: L0423Q108 
AUTHORIZED SIGNATURES: 
AVINASH RUGOOBUR 
DIRECTOR 
PETER CUNEO 
DIRECTOR 
KRISTEN O’HARA 
DIRECTOR 
REGISTERED SHARE CERTIFICATE 
ARRIVAL 
1, RUE PETERNELCHEN 
L-2370 HOWALD 
GRAND DUCHY OF LUXEMBOURG 

	
	

 DATED: 
SIGNATURE(S) GUARANTEED: 
The Signature(s) must be guaranteed by an eligible guarantor institution (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions with membership in an approved
Signature Guarantee Medallion Program, pursuant to S.E.C. Rule 17Ad-15 under the securities exchange act of 1934, as amended (or any successor rule)). 
Notice: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any
change whatever. 
Arrival 
The Company will furnish without charge to each
shareholder who so requests, a statement of the powers, designations, preferences and relative, participating, optional or other special rights of each class of equity or series thereof of the Company and the qualifications, limitations, or
restrictions of such preferences and/or rights. This certificate and the shares represented thereby are issued and shall beheld subject to all the provisions of the Articles of Association of the Company. The following abbreviations, when used in
the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: 
TEN COM:
as tenants in common 
TEN ENT: as tenants by the entireties 
JT TEN: as joint
tenants with right of survivorship and not as tenants in common 
UNIF GIFT MIN ACT: 
Custodian 
CUST 
MINOR 
under Uniform Gifts to Minors Act 
STATE 
Additional abbreviations may also be used though not in the above list.Exhibit
4.1

 

DESCRIPTION
OF SECURITIES

 

The
following description of our securities is only a summary and is qualified in its entirety by reference to the actual terms and provisions
of the capital stock contained in our amended and restated certificate of incorporation and our amended and restated by-laws.

 

General

 

EVmo,
Inc. (the “Company,” “we,” “our,” and “us”) is authorized to issue two
classes of stock. The total number of shares of stock which the Company is authorized to issue is 100,000,000 shares of capital
stock, consisting of 90,000,000 shares of common stock, $0.000001 par value per share, and 10,000,000 shares of preferred stock,
$0.000001 par value per share.

 

Common
stock

 

The
holders of our common stock are entitled to the following rights:

 

Voting
Rights

 

Each
share of our common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders.
Holders of our common stock are not entitled to cumulative voting rights with respect to the election of directors.

 

Dividend
Rights

 

Subject
to limitations under Delaware law and preferences that may apply to any shares of preferred stock that we may decide to issue in the
future, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may be declared
by our Board out of funds legally available therefor.

 

Liquidation
Rights

 

In
the event of the liquidation, dissolution or winding up of our business, the holders of our common stock are entitled to share ratably
in the assets available for distribution after the payment of all of our debts and other liabilities, subject to the prior rights of
the holders of our preferred stock.

 

Other
Matters

 

The
holders of our common stock have no subscription, redemption or conversion privileges. Our common stock does not entitle its holders
to preemptive rights. All of the outstanding shares of our common stock are fully paid and non-assessable. The rights, preferences and
privileges of the holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which
we may issue in the future.

 

Preferred
Stock

 

Our
authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.000001 per share. As of the date of this filing,
2,000,000 shares of preferred stock have been designated as Series A non-voting convertible preferred stock, none of which have been
issued. Our Board has the authority to issue preferred stock in one or more classes or series and to fix the designations, powers, preferences,
and rights, and the qualifications, limitations or restrictions thereof including dividend rights, dividend rates, conversion rights,
voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series,
without further vote or action by the stockholders. The Certificate of Designation, Preferences and Rights of our Series A Convertible
Preferred Stock has been filed with this annual report on Form 10-K as Exhibit 3.3.

 

    	 

     

    

 

While
we do not currently have any plans for the issuance of any preferred stock, the issuance of preferred stock could adversely affect the
rights of the holders of common stock and, therefore, reduce the value of the common stock. It is not possible to state the actual effect
of the issuance of any shares of preferred stock on the rights of holders of the common stock until the Board of Directors determines
the specific rights of the holders of the preferred stock; however, these effects may include:

 

	 	●	Restricting
    dividends on the common stock;
	 	●	Diluting
    the voting power of the common stock;
	 	●	Impairing
    the liquidation rights of the common stock; or
	 	●	Delaying
    or preventing a change-in-control of the Company without further action by the stockholders. 

 

Warrant

 

On
March 8, 2018, the Company issued a warrant to purchase a total of 1,500,000 shares of Company common stock at the exercise price of
$4.00 per share. The shares of Company common stock underlying this warrant were registered as part of our initial public offering. The
warrant has been filed with this annual report on Form 10-K as Exhibit 4.2

 

Options

 

2016
Equity Incentive Plan

 

On
November 30, 2016, we adopted our 2016 Equity Incentive Plan (the “Plan”) to reward and provide incentives to our officers,
directors, employees, consultants and other eligible participants. We set aside options to purchase up to 10,000,000 shares of common
stock for issuance under the Plan, which may be granted in the form of either incentive stock options or non-qualified stock options.
Our Board of Directors administers the Plan and has the authority: (i) to select the Plan recipients, the time or times at which awards
may be granted, the number of shares to be subject to each option awarded, the vesting schedule of the options, and the price at which
the options may be exercised, and (ii) to amend the Plan.ex_238344.htm

 

Exhibit 10.2

 

Amendment No. 1 to the 

BioLife Solutions, Inc. 

Second Amended and Restated 2013 Performance Incentive Plan

 

This Amendment No. 1 (the “Amendment”) to the BioLife Solutions, Inc. Second Amended and Restated 2013 Performance Incentive Plan (as amended, the “Plan”), is made effective as of July 9, 2020 by BioLife Solutions, Inc. (the “Company”).

 

WITNESSETH:

 

WHEREAS, the Plan was originally adopted by the Company’s Board of Directors on April 25, 2013 and approved by the Company’s stockholders on June 20, 2013, was amended and restated by the Company’s Board of Directors on February 19, 2015 and approved by the Company’s stockholders on May 4, 2015, and was again amended and restated by the Company’s Board of Directors on April 5, 2017 and approved by the Company’s stockholders on May 25, 2017;

 

WHEREAS, the Board has the authority pursuant to Article 9 of the Plan to amend the Plan subject to the approval of the stockholders entitled to vote in accordance with applicable law;

 

WHEREAS, the Board desires to amend the Plan to further increase the aggregate number of shares of common stock that may be issued under the Plan; and

 

WHEREAS, on May 19th, 2020, the Board approved Amendment No. 1 and recommend its approval to the stockholders;

 

NOW, THEREFORE, pursuant to the power of amendment set forth in the Plan and subject to the approval of Company’s stockholders, the Plan is hereby amended as follows effective upon the approval by the stockholders of Amendment No. 1:

 

1. The references to “4,100,000 shares” in the first paragraph of Article 4.1 of the Plan is replaced in their entirety with “5,000,000 shares”.

 

2. Except as hereinabove amended and modified, the Plan shall remain in full force and effect.

 

3. A majority of votes cast by the Stockholders present in person or by proxy and entitled to vote at the meeting of stockholders at which this Amendment No. 1 to the Plan was considered, has duly approved this Amendment No. 1 to the Plan.

 

IN WITNESS WHEREOF, this Amendment No. 1 to the Plan is made effective this 9th day of July, 2020.

 

	
			 

				
			BioLife Solutions, Inc. 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			By: 

				
			/s/ Roderick de Greef

				
			 

			
	
			 

				Name: Roderick de Greef	
			 

			
	
			 

				Title: CFO and COO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]